Bipartisan Senators Respond to Trump Administration's Federal Cannabis Rescheduling Initiative
Connecticut Lawmakers Reinstate THC Caps on Cannabis Flower and Concentrates
CSQ Introduces EU GMP Addendum to Facilitate Cannabinoid Export Compliance for European Markets
Federal Schedule III Reclassification Prompts State-Level Medical Cannabis Expansion and Regulatory Adjustments
White House National Drug Strategy Raises Alarm on High-Potency Marijuana, Affirms Federal Hemp THC Ban
Nebraskans for Medical Marijuana Conducts Statewide Town Halls on Program Implementation and Patient Access
U.S. House Advances Farm Bill, Establishing Separate Regulatory Pathways for Industrial Hemp and Cannabinoid Crops
DEA Classifies Synthetic Cannabinoid HHC as Schedule I Substance; Texas Hemp Sales Face New Rulings
Australian Medical Cannabis Sales Decline 28.5% Amid Increased Regulatory Enforcement
Warrnambool Driver Retains Licence Following Medical Cannabis Prescription Defence
